26 signals · bluesky, News / RSS
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
Insilico Medicine in the AI Drug Discovery space registers relatively low workforce stress signals and low overall risk indicators based on 3 signals across 1 source.
Signals for Insilico Medicine were collected from 1 source. Aggregate signal sentiment appears broadly positive. The stress score stands at 22/100 with a risk score of 3/100. Signal coverage is sufficient to support a preliminary assessment.
What this means
Signals indicate a relatively stable workplace environment based on available data.
AI-generated from public signals — may be incomplete.
Insilico Medicine shares rise as the company, in collaboration with an international team, unveils new Alzheimer’s disease targets and early biomarkers. 富途牛牛
Insilico Medicine shares rise as the company, in collaboration with an international team, unveils new Alzheimer’s disease targets and early biomarkers.
Insilico Medicine’s “watershed moment” as H1 revenue surpasses $100 million 富途牛牛
Artificial intelligence for drug discovery and aging.
Based on 26 signals across 2 sources · snapshot 6 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Insilico Medicine is positive based on public signals as of 6 Sept 2026.
Based on 26 signals across 2 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development Insilico Medicine